Approval · Notice of Compliance 33915 · 2022
ZYTIGA: Notice of Compliance 33915
Issued February 8, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 33915
- Date
- February 8, 2022
- Company
- Janssen Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to bottle labels
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZYTIGA | Not yet assigned | — |
Medicinal ingredients
- ABIRATERONE ACETATE 500 MG per TAB
- ABIRATERONE ACETATE 250 MG per TAB